Table 1 Clinical characteristics of Groups A and control
Variables | Control (n = 20) | Group A (n = 45) | P value |
|---|---|---|---|
Age (year) | 36 ± 8.9 | 38.4 ± 10.4 | 0.378 |
Gender | |||
Male n (%) | 8(40.0) | 24(53.3) | 0.321 |
Female n (%) | 12(60.0) | 21(46.7) | |
Family history of hepatitis B | |||
Yes n (%) | 6(30.0) | 11(24.4) | 0.638 |
No n (%) | 14(70.0) | 34(75.6) | |
ALT (U/L) | 27(21.5,35.8) | 25(19,44.5) | 0.915 |
AST (U/L) | 26.5(18.8,32) | 23(19,34) | 0.96 |
TBIL (umol/L) | 11.25(10.1,15.5) | 10.9(8.4,14.7) | 0.367 |
WBC (×109/L) | 5.8(5.2,7.1) | 5.6(4.7,7.2) | 0.271 |
PLT (×109/L) | 175.5(152.3,225) | 195(166,218) | 0.386 |
HBsAg IU/mL | 0 | 1202.1(34.8,4861.3) | < 0.05 |
HBV-DNA IU/mL | 0 | 796(0,407500) | < 0.05 |